Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by askretka


T.ONC

New 14 April Research Report highlights CAR-T

https://leedejonesgable.com/wp- content/uploads/ONC_2022_04_14.pdf ----------...

April 21, 2022

T.ONC

RE:RE:RE:Gilead sees 33% revenues will come from oncology by 2030

WHO), cancer is a growing burden, and the number of new cancer cases is going...

April 20, 2022

V.ISGI

RE:With all their recent contracts/signings

Well I'm traveling right now and every plane I've been on there are...

April 15, 2022

T.ONC

13 April Researchers load CAR-T cells with Oncolytic virus

https://www.sciencedaily.com/releases/2022/04/220413141538.htm --------------...

April 13, 2022

T.ONC

RE:RE:RE:RE:Pfizer and Merck KGaA win over NICE on Bavencio coverage

Yes it's positive for Oncolytics and breast cancer. A quick search shows...

April 8, 2022

T.ONC

RE:Pfizer and Merck KGaA win over NICE on Bavencio coverage

Intresting that Trodelvy that Gilead paid 21 Billion for was targeting...

April 8, 2022

T.ONC

RE:RE:FDA "Project FrontRunner" - to advance accelerated approvals

I wonder if this is anyway related to " Project Moonshot" that...

April 6, 2022

T.ONC

For Notable Re: Last CAR-T Virus post

You did a good summary there. It is interesting indeed that it may favor a...

April 5, 2022

T.ONC

CAR-T + Oncolytics Virus 02 Mar 2022

Highly technical article but interesting...

April 3, 2022

T.ONC

RE:Press release March 24th

https://pharmaboardroom.com/interviews/carsten-lu-ceo-adlai-nortye-china...

March 27, 2022

T.ONC

Nk cells 100 times cheaper than CAR-T??

https://pharmaphorum.com/news/natural-killer-cancer-therapy-a-hundred-times...

March 20, 2022

T.ONC

New Article in Immunology Journal

Oncolytics Biotech Announces Publication of Preclinical and Patient Data...

March 17, 2022

C.BULL

Russian bans exports on key commodities

Russia has now hit back with equally harsh sanctions as this economic war...

March 9, 2022

T.ONC

GILEAD layoffs

Gilead to lay off 110+ employees at former Immunomedics HQ in another ding...

March 9, 2022

C.BULL

Picked up small position at 0.13

Intresting deposit. Small footprint Now have 1 million oz Palladium...

March 8, 2022

T.ONC

RE:RE:RE:GILEAD'S 21 billion $ breast cancer drug fails?

ONC is in the same Market Breast Cancer and Gilead paid 21 Billion in a...

March 8, 2022

T.ONC

GILEAD'S 21 billion $ breast cancer drug fails?

Gilead draws harsh reviews as PhIII for $21B Immunomedics drug underwhelms...

March 8, 2022

V.RGD

Sprott research report and $ 0.50 target

https://sprott.com/media/4935/220124-rgd-scp-initiation.pdf -----------------...

March 7, 2022

T.GTWO

How to value a gold deposit

https://munknee.com/how-to-value-a-junior-miners-gold-in-the-ground/ --------...

March 7, 2022

T.ONC

New Report $ 8.50 CDN Target Maintained

https://leedejonesgable.com/wp-content/uploads/ONC_2022_03_04.pdf

March 5, 2022

Featured Company